AN2 Therapeutics
existing cash funds value driving milestones series a closed series closed march cash as of existing cash plus proceeds from provides expected capital to support operations for at least months phase topline data topline data adjuvant res of the a | AN2 Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2022
Slide
24 of 27
Related slides by other companies
Equillium
Investor Presentation
February 2024
diversified pipeline of first in class immunology assets first class | Equillium
Electronic Arts
Results
February 2022
growth topline to cash net revenue net bookings operating cash flow | Electronic Arts
NVIDIA
Investor Presentation
December 2020
highlights | NVIDIA
Baird
Investment Banking
July 2018
series unit cash flow comparison | Baird
Other recent decks by AN2 Therapeutics
See all presentations (2 decks)
Investor Presentation
August 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io